Insider · CIK 0001579247
Axel Bolte
Files at INZY (Inozyme Pharma, Inc.). First filing -, latest -.
In brief
Axel Bolte files SEC Form 4 as director at INZY (Inozyme Pharma, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Axel Bolte has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 8 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 1, 2025 | INZY Inozyme Pharma, Inc. | UTender of shares Common Stock | -423,926 | $4.00 | $1.7M | 0 | Jul 3, 2025 |
| Jul 1, 2025 | INZY Inozyme Pharma, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -234,176 | - | - | 0 | Jul 3, 2025 |
| Jul 1, 2025 | INZY Inozyme Pharma, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -159,187 | - | - | 0 | Jul 3, 2025 |
| May 15, 2025 | INZY Inozyme Pharma, Inc. | MOption exercise Common Stock | +152,823 | $0.98 | $150k | 419,519 | May 20, 2025 |
| May 15, 2025 | INZY Inozyme Pharma, Inc. | MOption exercise Common Stock | +4,407 | $0.98 | $4,319 | 423,926 | May 20, 2025 |
| May 15, 2025 | INZY Inozyme Pharma, Inc. | MOption exercise Stock Option (right to buy)derivative | -152,823 | $0.00 | $0 | 0 | May 20, 2025 |
| May 15, 2025 | INZY Inozyme Pharma, Inc. | MOption exercise Stock Option (right to buy)derivative | -4,407 | $0.00 | $0 | 0 | May 20, 2025 |
| Jun 18, 2024 | INZY Inozyme Pharma, Inc. | AGrant or award Stock Option (right to buy)derivative | +28,000 | $0.00 | $0 | 28,000 | Jun 20, 2024 |
Questions about Axel Bolte
Answered from the filings on this page, as of the latest one.
Is Axel Bolte buying or selling?
Axel Bolte has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Axel Bolte's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Axel Bolte has 0.
Where does Axel Bolte file Form 4?
Axel Bolte has filed Form 4 at INZY (Inozyme Pharma, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.